Angiotensin AT1 - α2C-adrenoceptor interaction disturbs α2A-auto-inhibition of catecholamine release in hypertensive rats

Frontiers in Neurology

Volumn 4 JUN, Issue , 2013, Pages

  Berg, Torill ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

2 adrenoceptors; Angiotensin AT1 receptor; Epinephrine; Norepinephrine; Release control; Spontaneously hypertensive rats; Sympathetic nervous system; Total peripheral vascular resistance

Indexed keywords

2 (2,6 DIETHYLANILINO) 2 IMIDAZOLINE; ADRENALIN; ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2C ADRENERGIC RECEPTOR; ANGIOTENSIN 1 RECEPTOR; CATECHOLAMINE; CLONIDINE; FADOLMIDINE; LOSARTAN; N [2 (1,3,4,6,7,12B HEXAHYDRO 2' OXOSPIRO[2H BENZOFURO[2,3 A]QUINOLIZINE 2,4' IMIDAZOLIDIN] 3' YL)ETHYL]METHANESULFONAMIDE; NORADRENALIN TRANSPORTER; RECEPTOR SUBTYPE; TYRAMINE;

ADRENALIN RELEASE; ANIMAL EXPERIMENT; AORTA FLOW; ARTERY CATHETER; ARTICLE; ASCENDING AORTA; BLOOD PRESSURE MONITORING; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE RELEASE; CONTROLLED STUDY; FEMORAL ARTERY; HEART OUTPUT; HORMONE INHIBITION; HORMONE RECEPTOR INTERACTION; MALE; NONHUMAN; NORADRENALIN RELEASE; PRESYNAPTIC POTENTIAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SURGICAL STRESS; VASCULAR RESISTANCE;

EID: 84883492579     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2013.00070     Document Type: Article

References (42)

1. Apparsundaram, S., Galli, A., Defelice, L. J., Hartzell, H. C., and Blakely, R. D. (1998). Acute regulation of norepinephrine transport: I. protein kinase C-linked muscarinic receptors influence transport capacity and transporter density in SK-N-SH cells. J. Pharmacol. Exp. Ther. 287, 733-743.
2. Berg, T. (2002). Analysis of the pressor response to the K+ channel inhibitor 4-aminopyridine. Eur. J. Pharmacol. 452, 325-337. doi:10.1016/S0014-2999(02)02306-3
3. Berg, T. (2003). The vascular response to the K+ channel inhibitor 4-aminopyridine in hypertensive rats. Eur. J. Pharmacol. 466, 301-310. doi:10.1016/S0014-2999(03)01555-3
4. Berg, T., Degerman, E., and Tasken, K. (2009). Increased cAMP signaling can ameliorate the hypertensive condition in spontaneously hypertensive rats. J. Vasc. Res. 46, 25-35. doi:10.1159/000135662
5. 2-adrenoceptor control of catecholamine release and total peripheral vascular resistance in hypertensive rats. Front. Neurol. 4:19. doi:10.3389/fneur.2013.00019
6. Berg, T., Piercey, B. W., and Jensen, J. (2010). Role of beta1-3-adrenoceptors in blood pressure control at rest and during tyramine-induced norepinephrine release in spontaneously hypertensive rats. Hypertension 55, 1224-1230. doi:10.1161/HYPERTENSIONAHA.109.149286
7. Berg, T., Walaas, S. I., Roberg, B. A., Huynh, T. T., and Jensen, J. (2012). Plasma norepinephrine in hypertensive rats reflects alpha(2)-adrenoceptor release control only when re-uptake is inhibited. Front. Neurol. 3:160. doi:10.3389/fneur.2012.00160
8. Brede, M., Nagy, G., Philipp, M., Sorensen, J. B., Lohse, M. J., and Hein, L. (2003). Differential control of adrenal and sympathetic catecholamine release by alpha 2-adrenoceptor subtypes. Mol. Endocrinol. 17, 1640-1646. doi:10.1210/me.2003-0035
9. 2-adrenergic receptor subtypes - novel functions uncovered in gene-targeted mouse models. Biol. Cell 96, 343-348. doi:10.1111/j.1768-322X.2004.tb01424.x
10. Chotani, M. A., Mitra, S., Su, B. Y., Flavahan, S., Eid, A. H., Clark, K. R., et al. (2004). Regulation of alpha(2)-adrenoceptors in human vascular smooth muscle cells. Am. J. Physiol. 286, H59-H67.
11. Clineschmidt, B. V., Pettibone, D. J., Lotti, V. J., Hucker, H. B., Sweeney, B. M., Reiss, D. R., et al. (1988). A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066. J. Pharmacol. Exp. Ther. 245, 32-40.
12. Cox, S. L., Schelb, V., Trendelenburg, A. U., and Starke, K. (2000). Enhancement of noradrenaline release by angiotensin II and bradykinin in mouse atria: evidence for cross-talk between G(q/11) protein- and G(i/o) protein-coupled receptors. Br. J. Pharmacol. 129, 1095-1102. doi:10.1038/sj.bjp.0703167
13. 2-adrenoreceptors profile modulation. 3.1 (R)-(+)-m-nitrobiphenyline, a new efficient and alpha2C-subtype selective agonist. J. Med. Chem. 50, 3964-3968. doi:10.1021/jm061487a
14. Eid, A. H., Maiti, K., Mitra, S., Chotani, M. A., Flavahan, S., Bailey, S. R., et al. (2007). Estrogen increases smooth muscle expression of alpha2C-adrenoceptors and cold-induced constriction of cutaneous arteries. Am. J. Physiol. 293, H1955-H1961.
15. Esler, M. (2011). The sympathetic nervous system through the ages: from Thomas Willis to resistant hypertension. Exp. Physiol. 96, 611-622. doi:10.1113/expphysiol.2011.052332
16. Görnemann, T., von, W. H., Kleuser, B., Villalon, C. M., Centurion, D., Jahnichen, S., et al. (2007). Characterization of the postjunctional alpha 2C-adrenoceptor mediating vasoconstriction to UK14304 in porcine pulmonary veins. Br. J. Pharmacol. 151, 186-194. doi:10.1038/sj.bjp.0707221
17. Guyenet, P. G. (2006). The sympathetic control of blood pressure. Nat. Rev. Neurosci. 7, 335-346. doi:10.1038/nrn1902
18. Hein, L., Altman, J. D., and Kobilka, B. K. (1999). Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission. Nature 402, 181-184. doi:10.1038/46040
19. Kopp, U. C., Cicha, M. Z., and Smith, L. A. (2011). Impaired interaction between efferent and afferent renal nerve activity in SHR involves increased activation of alpha2-adrenoceptors. Hypertension 57, 640-647. doi:10.1161/HYPERTENSIONAHA.110.166595
20. Kurnik, D., Friedman, E. A., Muszkat, M., Sofowora, G. G., Xie, H. G., Dupont, W. D., et al. (2008). Genetic variants in the alpha2C-adrenoceptor and G-protein contribute to ethnic differences in cardiovascular stress responses. Pharmacogenet. Genomics 18, 743-750. doi:10.1097/FPC.0b013e3282fee5a1
21. Lehtimaki, J., Leino, T., Koivisto, A., Viitamaa, T., Lehtimaki, T., Haapalinna, A., et al. (2008). In vitro and in vivo profiling of fadolmidine, a novel potent alpha(2)-adrenoceptor agonist with local mode of action. Eur. J. Pharmacol. 599, 65-71. doi:10.1016/j.ejphar.2008.10.003
22. Li, Z., Bains, J. S., and Ferguson, A. V. (1993). Functional evidence that the angiotensin antagonist losartan crosses the blood-brain barrier in the rat. Brain Res. Bull. 30, 33-39. doi:10.1016/0361-9230(93)90036-B
23. Link, R. E., Desai, K., Hein, L., Stevens, M. E., Chruscinski, A., Bernstein, D., et al. (1996). Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c. Science 273, 803-805. doi:10.1126/science.273.5276.803
24. Lymperopoulos, A., Rengo, G., Funakoshi, H., Eckhart, A. D., and Koch, W. J. (2007). Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure. Nat. Med. 13, 315-323. doi:10.1038/nm1553
25. MacDonald, E., Kobilka, B. K., and Scheinin, M. (1997). Gene targeting - homing in on alpha 2-adrenoceptor-subtype function. Trends Pharmacol. Sci. 18, 211-219. doi:10.1016/S0165-6147(97)90625-8
26. Makaritsis, K. P., Johns, C., Gavras, I., Altman, J. D., Handy, D. E., Bresnahan, M. R., et al. (1999). Sympathoinhibitory function of the alpha(2A)-adrenergic receptor subtype. Hypertension 34, 403-407. doi:10.1161/01.HYP.34.3.403
27. Matthews, K. A., Katholi, C. R., McCreath, H., Whooley, M. A., Williams, D. R., Zhu, S., et al. (2004). Blood pressure reactivity to psychological stress predicts hypertension in the CARDIA study. Circulation 110, 74-78. doi:10.1161/01.CIR.0000133415.37578.E4
28. Michel, M. C., and Rump, L. C. (1996). alpha-Adrenergic regulation of human renal function. Fundam. Clin. Pharmacol. 10, 493-503. doi:10.1111/j.1472-8206.1996.tb00606.
29. Moura, E., Afonso, J., Hein, L., and Vieira-Coelho, M. A. (2006). Alpha2-adrenoceptor subtypes involved in the regulation of catecholamine release from the adrenal medulla of mice. Br. J. Pharmacol. 149, 1049-1058. doi:10.1038/sj.bjp.0706950
30. Oldendorf, W. H. (1971). Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. Am. J. Physiol. 221, 1629-1639.
31. Park, J. W., Chung, H. W., Lee, E. J., Jung, K. H., Paik, J. Y., and Lee, K. H. (2013). alpha2-Adrenergic agonists including xylazine and dexmedetomidine inhibit norepinephrine transporter function in SK-N-SH cells. Neurosci. Lett. 541, 184-189. doi:10.1016/j.neulet.2013.02.022
32. Parker, L. K., Shanks, J. A., Kennard, J. A., and Brain, K. L. (2010). Dynamic monitoring of NET activity in mature murine sympathetic terminals using a fluorescent substrate. Br. J. Pharmacol. 159, 797-807. doi:10.1111/j.1476-5381.2009.00574.x
33. Remie, R., Van Rossum, J. X., Coppes, R. P., and Zaagsma, J. (1992). Dysfunctional presynaptic alpha 2-adrenoceptors expose facilitatory beta 2-adrenoceptors in the vasculature of spontaneously hypertensive rats. Eur. J. Pharmacol. 211, 257-261. doi:10.1016/0014-2999(92)90537-E
34. Shafaroudi, M. M., McBride, M., Deighan, C., Wokoma, A., MacMillan, J., Daly, C. J., et al. (2005). Two "knockout" mouse models demonstrate that aortic vasodilatation is mediated via alpha2a-adrenoceptors located on the endothelium. J. Pharmacol. Exp. Ther. 314, 804-810. doi:10.1124/jpet.105.085944
35. Small, K. M., McGraw, D. W., and Liggett, S. B. (2003). Pharmacology and physiology of human adrenergic receptor polymorphisms. Annu. Rev. Pharmacol. Toxicol. 43, 381-411. doi:10.1146/annurev.pharmtox.43.100901.135823
36. Small, K. M., Wagoner, L. E., Levin, A. M., Kardia, S. L., and Liggett, S. B. (2002). Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure. N. Engl. J. Med. 347, 1135-1142. doi:10.1056/NEJMoa020803
37. Starke, K. (2001). Presynaptic autoreceptors in the third decade: focus on alpha2-adrenoceptors. J. Neurochem. 78, 685-693. doi:10.1046/j.1471-4159.2001.00484.x
38. Takano, Y., Takano, M., and Yaksh, T. L. (1992). The effect of intrathecally administered imiloxan and WB4101: possible role of alpha 2-adrenoceptor subtypes in the spinal cord. Eur. J. Pharmacol. 219, 465-468. doi:10.1016/0014-2999(92)90490-U
39. Talaia, C., Queiroz, G., Pinheiro, H., Moura, D., and Goncalves, J. (2006). Involvement of G-protein betagamma subunits on the influence of inhibitory alpha2-autoreceptors on the angiotensin AT1-receptor modulation of noradrenaline release in the rat vas deferens. Neurochem. Int. 49, 698-707. doi:10.1016/j.neuint.2006.07.002
40. Trendelenburg, A. U., Meyer, A., Klebroff, W., Guimaraes, S., and Starke, K. (2003a). Crosstalk between presynaptic angiotensin receptors, bradykinin receptors and alpha 2-autoreceptors in sympathetic neurons: a study in alpha 2-adrenoceptor-deficient mice. Br. J. Pharmacol. 138, 1389-1402. doi:10.1038/sj.bjp.0705223
41. Trendelenburg, A. U., Philipp, M., Meyer, A., Klebroff, W., Hein, L., and Starke, K. (2003b). All three alpha2-adrenoceptor types serve as autoreceptors in postganglionic sympathetic neurons. Naunyn Schmiedebergs Arch. Pharmacol. 368, 504-512. doi:10.1007/s00210-003-0829-x
42. Zugck, C., Lossnitzer, D., Backs, J., Kristen, A., Kinscherf, R., and Haass, M. (2003). Increased cardiac norepinephrine release in spontaneously hypertensive rats: role of presynaptic alpha-2A adrenoceptors. J. Hypertens. 21, 1363-1369. doi:10.1097/00004872-200307000-00026